• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染者在当前抗逆转录病毒治疗时代的带状疱疹。

Herpes zoster among persons living with HIV in the current antiretroviral therapy era.

机构信息

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):203-7. doi: 10.1097/QAI.0b013e318266cd3c.

DOI:10.1097/QAI.0b013e318266cd3c
PMID:22766968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4154488/
Abstract

BACKGROUND

Previously, herpes zoster (HZ) was found to occur at a higher rate in the HIV population than the general population. However, there are limited data about the incidence, risk factors, and clinical outcomes of HZ in the current antiretroviral therapy (ART) era.

METHODS

We identified HZ episodes in an urban HIV clinic cohort between 2002 and 2009. Three controls were matched to each case, and conditional logistic regression was used to assess for risk factors associated with incident HZ cases. Logistic regression was used to assess for factors associated with complicated HZ.

RESULTS

One hundred eighty-three new HZ cases were identified in 4353 patients with 19,752 person-years (PY) of follow-up--an incidence rate 9.3/1000 PY. Cases were majority men (62%) and African American (75%), with a mean age of 39 years (interquartile range, 32-44 years). Fifty patients (28%) had complicated HZ with 12% developing postherpetic neuralgia. In multivariate regression, factors associated with the increased risk of HZ were having started ART within 90 days of the episode [adjusted odds ratio (AOR), 4.02; 95% confidence interval (CI), 1.31 to 12.41], having a viral load of >400 copies per milliliter (AOR, 1.49; 95% CI, 1.00 to 2.24), and having a CD4 <350 cells per cubic millimeter (AOR, 2.46; 95% CI, 1.42 to 4.23) or 350 to 500 cells per cubic millimeter (AOR, 2.02; 95% CI, 1.14 to 3.57) as compared with CD4 >500 cells per cubic millimeter.

CONCLUSIONS

The incidence of HZ is lower than previously reported in HIV cohorts but remains higher than the general population. Over one fourth of patients developed complicated HZ, which is remarkable given the young age of our population. Risk factors for HZ include markers of poor immune function, suggesting that appropriate ART may reduce the burden of HZ in this population.

摘要

背景

此前,在艾滋病毒人群中发现带状疱疹(HZ)的发生率高于一般人群。然而,在当前的抗逆转录病毒治疗(ART)时代,关于 HZ 的发病率、危险因素和临床结局的数据有限。

方法

我们在 2002 年至 2009 年间在一家城市艾滋病毒诊所队列中确定了 HZ 发作病例。每例病例匹配了 3 名对照,采用条件逻辑回归评估与 HZ 病例相关的危险因素。采用逻辑回归评估与复杂 HZ 相关的因素。

结果

在 4353 名患者的 19752 人年(PY)随访中,共发现 183 例新的 HZ 病例,发病率为 9.3/1000 PY。病例多数为男性(62%)和非裔美国人(75%),平均年龄为 39 岁(四分位距,32-44 岁)。50 例(28%)患者发生复杂 HZ,其中 12%发生带状疱疹后神经痛。多变量回归分析显示,HZ 风险增加的相关因素包括在发作后 90 天内开始 ART[调整优势比(AOR),4.02;95%置信区间(CI),1.31 至 12.41]、病毒载量>400 拷贝/毫升(AOR,1.49;95%CI,1.00 至 2.24)以及 CD4 细胞<350 个/立方毫米(AOR,2.46;95%CI,1.42 至 4.23)或 350 至 500 个/立方毫米(AOR,2.02;95%CI,1.14 至 3.57)与 CD4>500 个/立方毫米。

结论

HZ 的发病率低于之前在艾滋病毒队列中报告的发病率,但仍高于一般人群。超过四分之一的患者发生了复杂的 HZ,考虑到我们人群的年轻年龄,这一比例令人瞩目。HZ 的危险因素包括免疫功能不良的标志物,这表明适当的 ART 可能会降低该人群 HZ 的负担。

相似文献

1
Herpes zoster among persons living with HIV in the current antiretroviral therapy era.HIV 感染者在当前抗逆转录病毒治疗时代的带状疱疹。
J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):203-7. doi: 10.1097/QAI.0b013e318266cd3c.
2
The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.高效抗逆转录病毒治疗时代HIV患者带状疱疹的发病率、危险因素及后遗症
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):169-74. doi: 10.1097/01.qai.0000178408.62675.b0.
3
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.在联合抗逆转录病毒治疗时代,艾滋病毒感染成年人的带状疱疹发病率:来自 FHDH-ANRS CO4 队列的结果。
Clin Infect Dis. 2015 Apr 15;60(8):1269-77. doi: 10.1093/cid/ciu1161. Epub 2015 Jan 18.
4
Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.高效抗逆转录病毒治疗时代HIV-1感染患者的带状疱疹:一项前瞻性观察研究。
Int J STD AIDS. 2005 Oct;16(10):673-6. doi: 10.1258/095646205774357271.
5
Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.在德国艾滋病毒/艾滋病能力网络(KompNet)中,艾滋病毒阳性患者中带状疱疹的发病率和危险因素:队列研究分析。
BMC Infect Dis. 2013 Aug 10;13:372. doi: 10.1186/1471-2334-13-372.
6
Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.台湾地区开始联合抗逆转录病毒疗法的人类免疫缺陷病毒阳性患者中带状疱疹的发病率和危险因素。
J Microbiol Immunol Infect. 2018 Feb;51(1):38-44. doi: 10.1016/j.jmii.2016.04.011. Epub 2016 May 13.
7
Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.在南非约翰内斯堡开始接受抗逆转录病毒治疗的初治艾滋病毒患者中带状疱疹的发病率及预测因素
Int J Infect Dis. 2014 Jun;23:56-62. doi: 10.1016/j.ijid.2013.10.016. Epub 2014 Mar 25.
8
Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.高效抗逆转录病毒治疗时代带状疱疹发病率的下降。
Clin Infect Dis. 2013 Jul;57(1):122-5. doi: 10.1093/cid/cit165. Epub 2013 Mar 13.
9
Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.接受有效抗逆转录病毒治疗的HIV感染者带状疱疹的免疫相关性
AIDS Res Hum Retroviruses. 2019 Oct;35(10):890-895. doi: 10.1089/AID.2019.0053. Epub 2019 Jul 16.
10
Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.抗逆转录病毒疗法对坦桑尼亚人类免疫缺陷病毒感染者带状疱疹发病风险的影响。
Am J Trop Med Hyg. 2018 Feb;98(2):396-401. doi: 10.4269/ajtmh.17-0568. Epub 2018 Jan 4.

引用本文的文献

1
Predictive value of blood routine-derived inflammation indexes for varicella-zoster virus meningitis in patients with acute herpes zoster.血常规衍生炎症指标对急性带状疱疹患者水痘-带状疱疹病毒脑膜炎的预测价值
Front Cell Infect Microbiol. 2025 Jun 24;15:1617460. doi: 10.3389/fcimb.2025.1617460. eCollection 2025.
2
Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada.加拿大免疫功能低下成年特定人群中重组带状疱疹疫苗与不接种带状疱疹疫苗相比的成本效益及对公共卫生的影响
BMC Health Serv Res. 2025 Apr 25;25(1):604. doi: 10.1186/s12913-025-12550-x.
3

本文引用的文献

1
Herpes zoster among HIV-infected patients in the highly active antiretroviral therapy era: Korean HIV cohort study.高效抗逆转录病毒治疗时代HIV感染患者中的带状疱疹:韩国HIV队列研究
J Acquir Immune Defic Syndr. 2010 Mar;53(3):417-8. doi: 10.1097/QAI.0b013e3181b1d6dc.
2
Increasing incidence of herpes zoster among Veterans.带状疱疹在退伍军人中的发病率上升。
Clin Infect Dis. 2010 Apr 1;50(7):1000-5. doi: 10.1086/651078.
3
Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.
Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.
系统评价和荟萃分析在免疫功能低下人群中的重组带状疱疹疫苗。
PLoS One. 2024 Nov 25;19(11):e0313889. doi: 10.1371/journal.pone.0313889. eCollection 2024.
4
Burden of Vaccine-Preventable Diseases in People Living with HIV.艾滋病毒感染者中疫苗可预防疾病的负担
Vaccines (Basel). 2024 Jul 16;12(7):780. doi: 10.3390/vaccines12070780.
5
The Incidence of Herpes Zoster Complications: A Systematic Literature Review.带状疱疹并发症的发病率:一项系统文献综述。
Infect Dis Ther. 2024 Jul;13(7):1461-1486. doi: 10.1007/s40121-024-01002-4. Epub 2024 Jun 19.
6
Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review.减毒活疫苗和重组/灭活水痘带状疱疹疫苗在HIV感染者中的免疫原性和安全性:一项系统评价
Hum Vaccin Immunother. 2024 Dec 31;20(1):2341456. doi: 10.1080/21645515.2024.2341456. Epub 2024 Apr 22.
7
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.50 岁以上 HIV 感染者与非 HIV 年龄/性别匹配对照者对重组带状疱疹疫苗的免疫应答比较(SHINGR'HIV):一项多中心、国际、非随机临床试验研究方案。
BMC Infect Dis. 2024 Mar 19;24(1):329. doi: 10.1186/s12879-024-09192-5.
8
Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns.疱疹性感染的风险因素:系统综述和荟萃分析揭示了常见趋势和异质性模式。
Infection. 2024 Jun;52(3):1009-1026. doi: 10.1007/s15010-023-02156-y. Epub 2024 Jan 18.
9
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States.重组带状疱疹疫苗预防美国造血干细胞移植受者及其他免疫功能低下成人带状疱疹的成本效益分析
Pharmacoecon Open. 2023 Nov;7(6):975-985. doi: 10.1007/s41669-023-00438-7. Epub 2023 Nov 2.
10
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population.新型冠状病毒肺炎疫苗在自身免疫性疾病患者、有心脏问题的患者及健康人群中的安全性
Pathogens. 2023 Feb 2;12(2):233. doi: 10.3390/pathogens12020233.
美国2008年成人、青少年及18个月以下儿童HIV感染以及18个月至不满13岁儿童HIV感染与艾滋病监测病例定义修订版
MMWR Recomm Rep. 2008 Dec 5;57(RR-10):1-12.
4
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.研究电子数据采集(REDCap)——一种用于提供转化研究信息学支持的元数据驱动方法和工作流程。
J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
5
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).带状疱疹的预防:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.
6
A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.一项在引入带状疱疹疫苗之前基于人群的带状疱疹发病率和并发症发生率研究。
Mayo Clin Proc. 2007 Nov;82(11):1341-9. doi: 10.4065/82.11.1341.
7
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).水痘预防:免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40.
8
The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.高效抗逆转录病毒治疗时代HIV患者带状疱疹的发病率、危险因素及后遗症
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):169-74. doi: 10.1097/01.qai.0000178408.62675.b0.
9
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.一种预防老年人带状疱疹及带状疱疹后神经痛的疫苗。
N Engl J Med. 2005 Jun 2;352(22):2271-84. doi: 10.1056/NEJMoa051016.
10
Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study.感染HIV及有感染风险的女性中的带状疱疹:来自女性机构间HIV研究的数据。
J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1604-9. doi: 10.1097/00126334-200412150-00013.